Autism spectrum disorder (ASD) is a neurodevelopmental disease associated with various gene mutations. Recent genetic and clinical studies report that mutations of the epigenetic gene ASH1L are highly associated with human ASD and intellectual disability (ID). However, the causality and underlying molecular mechanisms linking ASH1L mutations to genesis of ASD/ID remain undetermined. Here we show loss of ASH1L in the developing mouse brain is sufficient to cause multiple developmental defects, core autistic-like behaviors, and impaired cognitive memory. Gene expression analyses uncover critical roles of ASH1L in regulating gene expression during neural cell development. Thus, our study establishes an ASD/ID mouse model revealing the critical function of an epigenetic factor ASH1L in normal brain development, a causality between Ash1L mutations and ASD/ID-like behaviors in mice, and potential molecular mechanisms linking Ash1L mutations to brain functional abnormalities.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213741PMC
http://dx.doi.org/10.1038/s42003-021-02282-zDOI Listing

Publication Analysis

Top Keywords

ash1l mutations
12
ash1l
8
ash1l developing
8
developing mouse
8
mouse brain
8
autistic-like behaviors
8
molecular mechanisms
8
mechanisms linking
8
linking ash1l
8
gene expression
8

Similar Publications

Precise regulation of the chromatin environment through post-translational histone modification modulates transcription and controls brain development. Not surprisingly, mutations in a large number of histone-modifying enzymes underlie complex brain disorders. In particular, the histone methyltransferase ASH1L modifies histone marks linked to transcriptional activation and has been implicated in multiple neuropsychiatric disorders.

View Article and Find Full Text PDF
Article Synopsis
  • Congenital malformations of the female genital tract (CM-FGT) involve abnormal development of reproductive organs and can also affect other systems, with no identified genetic causes until now.
  • A comprehensive whole-genome sequencing study was conducted on 590 participants in China, discovering various genetic anomalies associated with CM-FGT, including novel variants and highlighting ASH1L as a key pathogenic gene.
  • The study's findings enhance the understanding of the genetic factors contributing to CM-FGT and suggest potential for prenatal screening based on the identified spatiotemporal gene expression patterns during early uterine development.
View Article and Find Full Text PDF

Background: Histone methyltransferase absent, small, or homeotic discs1-like () is composed of su(var)3-9, enhancer of zeste, trithorax (SET) domain, pleckstrin homology domain (PHD) domain, middle (MID) domain, and bromo adjacent homology (BAH) domain. The SET domain of is known to mediate mediate H3K36 dimethylation (H3K36me2) modification. However, the specific functions of the PHD-BAH domain remain largely unexplored.

View Article and Find Full Text PDF
Article Synopsis
  • The study explored the use of next-generation sequencing (NGS) to identify genetic variants in 55 children with childhood epilepsy of unknown origins, ultimately diagnosing about 50.9% of the cases.* -
  • Researchers found variants in 22 different epilepsy-associated genes, with significant findings related to SCN1A, ALDH7A1, and KCNQ2, which could inform targeted therapies for some patients.* -
  • The discovery of novel genetic variants enhances the understanding of the genetic factors linked to childhood epilepsy and aims to improve diagnosis and treatment strategies globally.*
View Article and Find Full Text PDF

The histone methyltransferase ASH1L, first discovered for its role in transcription, has been shown to accelerate the removal of ultraviolet (UV) light-induced cyclobutane pyrimidine dimers (CPDs) by nucleotide excision repair. Previous reports demonstrated that CPD excision is most efficient at transcriptional regulatory elements, including enhancers, relative to other genomic sites. Therefore, we analyzed DNA damage maps in ASH1L-proficient and ASH1L-deficient cells to understand how ASH1L controls enhancer stability.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!